Document is current
Any future updates will be listed below
-
Authors
Bansback, Nick
Tam, Alexander C.T.
Palis, Heather
Kanters, Steve
Popoff, Evan
Schechter, Martin T.
Anis, Aslam H.
Marsh, David C.
Oviedo-Joekes, Eugenia
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (Project Grant: Network Meta-Analysis of Opioid Agonist Treatments for street opioid users, Project Grant: Network Meta-Analysis of Opioid Agonist Treatments for street opioid users, Project Grant: Network Meta-Analysis of Opioid Agonist Treatments for street opioid users, Project Grant: Network Meta-Analysis of Opioid Agonist Treatments for street opioid users, Project Grant: Network Meta-Analysis of Opioid Agonist Treatments for street opioid users, Project Grant: Network Meta-Analysis of Opioid Agonist Treatments for street opioid users)
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 8 August 2025
First Online: 30 August 2025
Declarations
:
: Not applicable.
: Not applicable.
: MTS is a Member of the Board of the Michael Smith Health Research BC and holds grants from the Canadian Institutes of Health Research. MTS is a principal in Fair Price Pharma, a company whose aim is to produce licensed, prescribed medications to address the toxic drug crisis. SK and EP report employment at RainCity Analytics – a consulting company. All other authors declare no competing interests.
